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SHORT REPORT
Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using
Dual-Energy X-ray Absorptiometry Scanning
Catherine Hornby a, Hannah Botfielda, Michael W. O’Reillya,b, Connar Westgatea, James Mitchella,b,c,
Susan P. Mollana,d, Konstantinos Manolopoulosa,b, Jeremy Tomlinsonb,e, and Alexandra Sinclaira,b,c
aInstitute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United
Kingdom; bCentre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom; cDepartment of
Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; dBirmingham Neuro-Ophthalmology Unit,
Ophthalmology Department, University Hospitals Birmingham NHS Trust, Queen Elizabeth Hospital Birmingham, Birmingham, United
Kingdom; eOxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, United Kingdom
ABSTRACT
Idiopathic intracranial hypertension (IIH) is strongly associated with obesity. We aimed to utilise
dual-energy X-ray absorptiometry (DEXA) to characterise fat distribution, and to evaluate change
in fat mass and distribution following weight loss. IIH patients (n = 24) had a similar fat distribu-
tion to body mass index (BMI)– and gender-matched obese controls (n = 47). In the IIH cohort,
truncal fat mass correlated with lumbar puncture pressure. Weight loss in IIH patients resulted in a
significant reduction in disease activity and fat mass, predominantly from the truncal region
(−4.40 ± 1.6%; p = 0.008) compared with the limbs (+0.79 ± 6.5%; p = 0.71). These results indicate
that, contrary to previous studies using waist-hip ratios, IIH adiposity is centripetal, similar to
simple obesity. Future studies should establish the risk of the metabolic syndrome and the role of
adipose tissue depot–specific function in IIH.
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Idiopathic intracranial hypertension (IIH) is a
condition of raised intracranial pressure (ICP) of
unknown cause.1 The presentation is variable but
typically includes chronic headaches and, in the
majority, papilloedema that can result in visual
decline.2 IIH has a striking phenotype of young,
obese women of childbearing age.2,3 There is
clearly a strong association between the condition
and obesity, which is seen in over 90% of IIH
patients,3 and weight loss has been shown to
resolve symptoms and improve clinical parameters
of IIH. However, not all obese patients develop
IIH, and it is not known whether the pattern of
body fat distribution could contribute to develop-
ment of disease.4 This is of particular interest,
given the well-known association between abdom-
inal (upper) and gluteofemoral (lower) body fat
ratios and the risk of cardiometabolic diseases.5,6
We aimed to characterise the fat distribution of
women with IIH compared with controls using the
gold-standard dual-energy X-ray absorptiometry
(DEXA) scanning technique, which has not been
previously used to evaluate fat mass, fat distribu-
tion, or percentage body fat in IIH. This technique
measures fat mass and distribution for total body
and regional areas and is significantly more accu-
rate than waist-hip ratios, which are prone to
inaccuracy due to inconsistent identification of
the waist in obese patients.7
Materials and methods
Patients with active IIH were recruited as pre-
viously described, and the control cohort was
composed of patients with simple obesity.8,9
DEXA was performed using a total-body scan-
ner (QDR 4500; Hologic, Bedford, MA, USA), as
previously described.9,10 The scans were adminis-
tered by a clinical scientist and trained radiogra-
pher. Patients with metal prosthetics or implants
were included, and tissue overlying the prosthesis
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was excluded from analysis. Scans were checked
for accuracy of fields of measurement. Regional fat
mass was analysed as described previously.9–11 The
precision of total fat mass measures in terms of
coefficients of variation (CV) was less than 3%,
and for regional fat analyses it was less than 5%.
Regional fat data were expressed as a percentage of
the total body fat. Both the IIH and control
cohorts were analysed on the same DEXA scanner
over the same time period.
Lipid profiling (cholesterol and triglycerides)
were performed in both IIH and control cohorts
to assess risk factors for the metabolic syndrome.
Total cholesterol and triglycerides were measured
following an overnight fast from midnight.
Furthermore, the IIH cohort also underwent a
weight loss intervention, during which they lost on
average 15% of body weight, as previously
described.8 The intervention used a previously
validated, low-energy total meal replacement
liquid diet (Lipotrim; Howard Foundation,
Cambridge, UK), providing 425 kcal/day, for 3
months.12 Patients were unable to consume addi-
tional food but were instructed to drink at least 2 L
of fluid a day. This was followed by further DEXA
scanning. We therefore also assessed the influence
of therapeutic weight loss on fat distribution in
IIH. A small subset of the control cohort were
evaluated using the same pre– and post–weight
loss protocol.13 This cohort underwent the same
diet intervention as the IIH patients.
Measures of IIH severity were measured before
and after weight loss intervention. Intracranial
pressure was measured using lumbar puncture
(LP), with measurements taken with the patient
lying in the left lateral position, with legs extended
greater than 90° at the hip. Adequate time was
taken to ensure a stable pressure reading.
Papilloedema was assessed using optical coherence
tomography (Stratus OCT V4.0.1; Carl Zeiss,
Meditec, Welwyn Garden City, UK), peripapillary
circle scan of the average retinal nerve fibre layer
thickness (µm), and masked papilloedema grading
of fundus photographs by a neuro-ophthalmolo-
gist (Frisen grading14).
This study was approved by the Dudley local
research ethics committee (06/Q2702/64) and the
South Birmingham Local Research Ethics
Committee (04/Q2707/278).
Statistical analysis
Statistical analysis was performed using SPSS ver-
sions 14 and 15 (SPSS Inc., Chicago, IL, USA) and
GraphPad Prism 7 for Mac OS X (GraphPad
Software Inc., La Jolla, CA, USA). Data are
reported using mean and standard deviation.
Spearman’s rank correlation coefficient was used
for assessing correlation of non-parametric data.
Correlation data were subject to multiple compar-
isons and consequently a Bonferroni correction
was applied. Mann-Whitney U tests were used
for assessment of non-parametric data. Data from
the right and left eyes yielded analogous results
and correlated significantly; consequently, data
from the right eye only are listed. The level at
which results were judged significant was p < 0.05.
Results
IIH patients (n = 24) were compared with a gen-
der- and body mass index (BMI)–matched control
cohort (n = 47) (mean BMI was 36.2 ± 3.7 kg/m2
in IIH and 34.5 ± 4.3 kg/m2 in controls; p = 0.08).
Cohorts were not matched for age, with the con-
trol cohort being significantly older than the IIH
cohort (49.1 ± 6.9 vs. 32.8 ± 8.6 years, respec-
tively). Waist measurements showed no significant
difference between the two groups (106.5 ± 9.7 cm
in the IIH group and 104.2 ± 9.7 cm in controls; p
= 0.343).
The DEXA scanner was able to accommodate all
patients enrolled in the study. The DEXA scanning
illustrated no difference in trunk and limb fat dis-
tribution in IIH patients compared with women with
simple obesity (Figure 1). Trunk fat in IIH was 20.5
± 3.2 kg compared with 19.9 ± 5.2 kg in controls (p =
0.19), whereas limb fat in IIH was 20.5 ± 5.0 kg and
in controls was 18.3 ± 4.3 kg (p = 0.14). Although the
ages were not matched, age did not appear to affect
results, as there was no difference in fat distribution
between IIH and control subjects following multi-
variate regression analysis, taking into account age as
a covariate. Interestingly, truncal fat mass correlated
with LP pressure in the IIH cohort (r = 0.527, p =
0.008; Figure 1). There was no significant correlation
between LP pressure and BMI or limb fat mass; total
fat mass and waist circumference showed a trend
towards an association, but this failed to reach





























statistical significance set to p = 0.01 once a
Bonferroni correction was applied (Table 1). There
was no correlation between papilloedema (measured
by average retinal nerve fibre layer thickness on
optical coherence tomography and Frisen grading)
and the anthropological measures (BMI and waist
circumference) and DEXA distribution data (total,
truncal, and limb fat mass).
We previously demonstrated significant weight
loss that corresponded to improvement in LP pres-
sure and papilloedema.8 The DEXA scanning
revealed that although fat mass reduced
significantly from all areas following the diet,
when analysing change in fat mass as a percentage
of total body fat mass, the fat mass was predomi-
nantly lost from the truncal region (−4.40 ± 1.6%;
p = 0.008), compared with limbs (+0.79 ± 6.5%; p
= 0.71; see Figure 1). However, these data demon-
strate that the change in fat mass and distribution
measured by DEXA did not correlate with changes
in ICP or papilloedema.
A small subset of the control cohort also underwent
the weight loss intervention and post–weight loss
DEXA scanning (n = 13). Controls lost a similar
Figure 1. Fat distribution in IIH and response to weight loss. Example DEXA imaging before (A) and after (B) weight loss. (C) Correlation
between truncal fat mass and lumbar puncture (LP) pressure. (D) Fat mass distribution in IIH compared with controls. (E) Percentages of fat
mass in IIH before and after weight loss (*p < 0.05).
Table 1. Correlation analysis of anthropological measures and DEXA scanning fat distribution data against lumbar
puncture (LP) pressure and papilloedema as measured by optical coherence tomography (OCT) peripapillary circle












LP pressure (cm CSF) r = 0.018 r = 0.461 r = 0.510 r = 0.527 r = 0.397
p = 0.934 p = 0.023 p = 0.011 p = 0.008** p = 0.055
OCT (µm) r = 0.199 r = 0.215 r = 0.276 r = 0.183 r = 0.314
p = 0.351 p = 0.312 p = 0.192 p = 0.391 p = 0.1335
Note. IIH = idiopathic intracranial hypertension. The level of statistical significance was adjusted to p < 0.01 following a Bonferroni






























amount ofweight comparedwith IIHpatients (weight
loss in the IIH cohort undergoing DEXA scanning
was −15.2 ± 3.0 kg compared with 13.3 ± 4.4 kg in
controls; p = 0.775; see Table 2). Fat mass was lost in a
similar distribution to that seen in IIH (truncal fat
mass lost in IIH was −4.40 ± 21.6 kg compared with
−4.9 ± 2.4 kg in controls; p = 0.870; Table 2).
Discussion
In summary, we have used DEXA scanning to
objectively quantify fat distribution in IIH and
find that it is centripetal, mirroring that of simple
obesity. Previous studies, from a single study cen-
tre, using waist-hip ratios, have identified prefer-
ential lower body fat accumulation in IIH.15,16
This has not been our experience. These previous
findings may be in relation to the tendency for
gluteofemoral fat to “accumulate” in the typical
female fat distribution, as seen in previous
studies.5 Clinical resolution of IIH occurs follow-
ing a loss of truncal fat, potentially implicating
central obesity in the pathogenesis of IIH. We
found that this degree and pattern of weight loss
was similar to that in obese controls, although as
the number of controls is small, this analysis is
limited. The importance of truncal fat is in line
with many previous studies showing a strong cor-
relation between abdominal fat accumulation and
adverse health outcomes, such as an increased
cardiovascular risk, dyslipidaemia, insulin resis-
tance, and type 2 diabetes.17–19 Importantly, total
abdominal fat mass, as measured by waist circum-
ference or DEXA, is determined by the mass of
two distinct adipose tissue depots, the subcuta-
neous and the visceral depot, with the latter parti-
cularly contributing to the adverse effects of
central obesity.20,21 Weight loss is associated with
overall reductions in total body fat mass, whereby
there appears to be gender- and depot-specific
differences.22,23 Our data are in line with previous
studies in women, showing reductions in abdom-
inal fat mass following dietary intervention.24,25
Of interest, we found that truncal fat mass, but
not BMI, was significantly correlated with LP pres-
sure. In studies of patients with mixed neurologi-
cal conditions, obesity as measured by BMI did
not correlate with LP pressure, but truncal adip-
osity has not been widely evaluated.26 We did not
find an association between change in DEXA fat
distribution (total, truncal, or limb fat), BMI, or
waist circumference and changes in LP pressure or
papilloedema.
Conclusion
The exact pathophysiological mechanism under-
pinning the relationship between body fat distri-
bution, the female gender predominance, and the
development of IIH remains unknown. This
study highlights that patients with IIH have a
similar distribution of fat mass to patients with
simple obesity. Truncal fat may have pathological
importance in IIH, as we noted that truncal fat
Table 2. Demographics of the subset of IIH and obese control patients undergoing the weight
loss intervention.
Characteristic IIH Control p-value
Number 22 13
Gender (% female) 100 100
Age (years) 34.4 ± 9.2 40.4 ± 13.5 0.224
Weight (kg) 101.3 ±16.5 100.4 ± 12.5 0.863
BMI (kg/m2) 37.9 ± 4.9 36.5 ± 4.8 0.369
Waist (cm) 111.1 ± 10.4 104.3 ± 7.8 0.043
Change following weight loss
Weight (kg) −15.2 ± 3.0 −13.3 ± 4.4 0.775
BMI (kg/m2) −5.8 ± 3.0 −4.8 ± 1.5 0.555
Waist (cm) −9.4 ± 5.9 −10.4 ± 5.5 0.649
DEXA
Total fat mass (kg) −9.10 ± 4.7 −9.3 ± 3.4 0.957
Total fat (%) −4.1 ± 2.7 −4.0 ± 2.4 0.986
Trunk fat mass (kg) −4.40 ± 21.6 −4.9 ± 2.4 0.870
Note. BMI = body mass index; DEXA = dual-energy X-ray absorptiometry; IIH = idiopathic intracranial
hypertension. Values are shown as mean ± standard deviation.





























mass was correlated with LP pressure.
Additionally, resolution of IIH following weight
loss was associated with preferential loss of adip-
osity from the truncal region. Future research
into the role of adipose tissue depot–specific
function, including the secretion of adipokines
and inflammatory factors, in regulating ICP is
required. Additionally, future evaluation to estab-
lish if IIH patients have an increased risk of
metabolic syndrome will have implications for
long-term morbidity.
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